Literature DB >> 1779618

Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.

M Midorikawa1, K Inui, S Okada, H Yabuuchi, K Ogura, S Handa.   

Abstract

The uptake and metabolism of [3-3H-sphingosine]GM1-ganglioside was measured in cultured skin fibroblasts from controls and patients with infantile, juvenile and adult GM1-gangliosidosis. When dissolved in medium with phosphatidylserine, GM1-ganglioside was efficiently taken up by cultured skin fibroblasts and transferred into lysosomes. A linear increase in GM1-ganglioside endocytosis was shown with phosphatidylserine concentrations of up to 40 micrograms/ml. A pulse-chase study revealed that [3H]GM1-ganglioside was metabolized to GM2-ganglioside, GM3-ganglioside, ceramide dihexoside, ceramide monohexoside, ceramide and sphingosine. Sphingosine was recycled to sphingomyelin. In a 20-h pulse study, cell lines from patients with GM1-gangliosidosis of infantile, juvenile and adult types hydrolysed 2-5%, 20-44% and 54-58% of the total endocytosed GM1-ganglioside respectively. These values were lower than in control cells (64.17 +/- 5.43% (n = 10]. The hydrolysis rates of exogenous [3H]GM1-ganglioside in cultured fibroblasts from patients with various types of GM1-gangliosidosis closely reflected the clinical severity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779618     DOI: 10.1007/bf01799941

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.

Authors:  T Kobayashi; N Shinnoh; Y Kuroiwa
Journal:  Biochim Biophys Acta       Date:  1986-01-03

2.  Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.

Authors:  G M Mancini; A T Hoogeveen; H Galjaard; J E Mansson; L Svennerholm
Journal:  Hum Genet       Date:  1986-05       Impact factor: 4.132

3.  G-M1-gangliosidosis. Correlation of clinical and biochemical data.

Authors:  Y Suzuki; A C Crocker; K Suzuki
Journal:  Arch Neurol       Date:  1971-01

4.  Clinical and enzymatic variations in G M1 generalized gangliosidosis.

Authors:  H S Singer; I A Schafer
Journal:  Am J Hum Genet       Date:  1972-07       Impact factor: 11.025

5.  A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy.

Authors:  M T Porter; A L Fluharty; J Trammell; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1971-08-06       Impact factor: 3.575

6.  Chronic GM1 gangliosidosis presenting as dystonia: II. Biochemical studies.

Authors:  T Kobayashi; K Suzuki
Journal:  Ann Neurol       Date:  1981-05       Impact factor: 10.422

7.  Specific tritium labeling of gangliosides at the 3-position of sphingosines.

Authors:  R Ghidoni; S Sonnino; M Masserini; P Orlando; G Tettamanti
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

8.  Generalized gangliosidosis: beta-galactosidase deficiency.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1968-05-31       Impact factor: 47.728

9.  Preparation of GM1 ganglioside molecular species having homogeneous fatty acid and long chain base moieties.

Authors:  S Sonnino; G Kirschner; R Ghidoni; D Acquotti; G Tettamanti
Journal:  J Lipid Res       Date:  1985-02       Impact factor: 5.922

10.  Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.

Authors:  S Sonderfeld; E Conzelmann; G Schwarzmann; J Burg; U Hinrichs; K Sandhoff
Journal:  Eur J Biochem       Date:  1985-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.